Cardiovascular magnetic resonance in women with cardiovascular disease: position statement from the Society for Cardiovascular Magnetic Resonance (SCMR)

Forskningsoutput: TidskriftsbidragÖversiktsartikel

Abstract

This document is a position statement from the Society for Cardiovascular Magnetic Resonance (SCMR) on recommendations for clinical utilization of cardiovascular magnetic resonance (CMR) in women with cardiovascular disease. The document was prepared by the SCMR Consensus Group on CMR Imaging for Female Patients with Cardiovascular Disease and endorsed by the SCMR Publications Committee and SCMR Executive Committee. The goals of this document are to (1) guide the informed selection of cardiovascular imaging methods, (2) inform clinical decision-making, (3) educate stakeholders on the advantages of CMR in specific clinical scenarios, and (4) empower patients with clinical evidence to participate in their clinical care. The statements of clinical utility presented in the current document pertain to the following clinical scenarios: acute coronary syndrome, stable ischemic heart disease, peripartum cardiomyopathy, cancer therapy-related cardiac dysfunction, aortic syndrome and congenital heart disease in pregnancy, bicuspid aortic valve and aortopathies, systemic rheumatic diseases and collagen vascular disorders, and cardiomyopathy-causing mutations. The authors cite published evidence when available and provide expert consensus otherwise. Most of the evidence available pertains to translational studies involving subjects of both sexes. However, the authors have prioritized review of data obtained from female patients, and direct comparison of CMR between women and men. This position statement does not consider CMR accessibility or availability of local expertise, but instead highlights the optimal utilization of CMR in women with known or suspected cardiovascular disease. Finally, the ultimate goal of this position statement is to improve the health of female patients with cardiovascular disease by providing specific recommendations on the use of CMR.

Detaljer

Författare
  • Karen G. Ordovas
  • Lauren A. Baldassarre
  • Chiara Bucciarelli-Ducci
  • James Carr
  • Juliano Lara Fernandes
  • Vanessa M. Ferreira
  • Luba Frank
  • Sophie Mavrogeni
  • Ntobeko Ntusi
  • Ellen Ostenfeld
  • Purvi Parwani
  • Alessia Pepe
  • Subha V. Raman
  • Hajime Sakuma
  • Jeanette Schulz-Menger
  • Lilia M. Sierra-Galan
  • Anne Marie Valente
  • Monvadi B. Srichai
Enheter & grupper
Externa organisationer
  • University of Washington
  • Yale University
  • NIHR Biomedical Research Centre
  • University of Bristol
  • Northwestern University Feinberg School of Medicine
  • University of Oxford
  • Medical College of Wisconsin
  • Onassis Cardiac Surgery Center, Athens
  • National and Kapodistrian University of Athens
  • University of Cape Town
  • Groote Schuur Hospital
  • Skåne University Hospital
  • Loma Linda University
  • Gabriele Monasterio Foundation
  • Indiana University-Purdue University Indianapolis
  • Brigham and Women's Hospital, Boston
  • Georgetown University
  • Mie University
  • Charité Universitätsmedizin Berlin
  • HELIOS Klinikum Berlin-Buch
  • American British Cowdray Medical Center (ABC Hospital)
Forskningsområden

Ämnesklassifikation (UKÄ) – OBLIGATORISK

  • Kardiologi

Nyckelord

Originalspråkengelska
Artikelnummer52
TidskriftJournal of Cardiovascular Magnetic Resonance
Volym23
StatusPublished - 2021 dec
PublikationskategoriForskning
Peer review utfördJa